Francis Van Parys Purchases 96 Shares of Oxford Nanopore Technologies (LON:ONT) Stock

Key Points

• Insider buying: Francis Van Parys purchased 96 Oxford Nanopore Technologies shares at GBX 157 each, valued at £150.72. This follows purchases in July and August.
• Stock performance and fundamentals: ONT shares recently traded at GBX 155.98, with a £1.52 billion market capitalization. The company remains unprofitable, reporting quarterly EPS of negative GBX 4.90 and a negative net margin of 54.66%.
• Analyst outlook: Five analysts rate the stock Buy and one rates it Hold, producing a consensus “Moderate Buy” rating and an average price target of GBX 198.60, above the recent trading price.

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) insider Francis Van Parys acquired 96 shares of the firm's stock in a transaction on Monday, September 14th. The stock was purchased at an average price of GBX 157 per share, with a total value of £150.72.

Francis Van Parys also recently made the following trade(s):

• On Wednesday, August 12th, Francis Van Parys acquired 114 shares of Oxford Nanopore Technologies stock. The shares were purchased at an average cost of GBX 131 per share, with a total value of £149.34.
• On Tuesday, July 14th, Francis Van Parys bought 124 shares of Oxford Nanopore Technologies stock. The shares were acquired at an average price of GBX 121 per share, with a total value of £150.04.

Oxford Nanopore Technologies Stock Performance

Shares of Oxford Nanopore Technologies stock traded down GBX 0.05 during trading hours on Monday, reaching GBX 155.98. The company had a trading volume of 1,072,999 shares, compared to its average volume of 10,261,299. Oxford Nanopore Technologies plc has a one year low of GBX 95.61 and a one year high of GBX 191.40. The firm has a market cap of £1.52 billion, a PE ratio of -12.48 and a beta of 0.96. The company has a debt-to-equity ratio of 9.86, a current ratio of 3.52 and a quick ratio of 6.01. The business has a fifty day simple moving average of GBX 134.37 and a 200 day simple moving average of GBX 125.65.

Oxford Nanopore Technologies (LON:ONT - Get Free Report) last posted its quarterly earnings data on Wednesday, August 19th. The company reported GBX (4.90) earnings per share for the quarter. Oxford Nanopore Technologies had a negative return on equity of 35.45% and a negative net margin of 54.66%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on ONT shares. Royal Bank Of Canada restated an "outperform" rating and set a GBX 225 price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Berenberg Bank lowered their price target on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a "buy" rating for the company in a report on Wednesday, August 19th. Citigroup cut shares of Oxford Nanopore Technologies to a "buy" rating in a research report on Monday, July 20th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 195 price target on shares of Oxford Nanopore Technologies in a report on Thursday, August 20th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the company an "overweight" rating in a research note on Thursday, August 27th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of GBX 198.60.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.